Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | Ventricular Assist Devices (VAD)

April 5, 2019 — Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) ...

Home April 05, 2019
Home
Technology | Radiation Dose Management

April 4, 2019 — The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer ...

Home April 04, 2019
Home
News | Heart Valve Technology

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...

Home April 03, 2019
Home
Technology | Stents

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...

Home April 03, 2019
Home
Technology | Venous Therapies

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

Home April 03, 2019
Home
Technology | Vascular Closure Devices

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

Home April 03, 2019
Home
Technology

April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...

Home April 03, 2019
Home
The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.
Feature
April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...
Home April 01, 2019
Home
All major vendors offering advanced visualization software now offer structural heart planning. This is an example of GE Healthcare's Valve Assist software being used to determine the best location of a transseptal puncture to deliver a left atrial appendage (LAA) occluder.
Feature | Structural Heart | Jeff Zagoudis
Structural heart interventions represent one of the fastest growing segments of cardiology, as the number of devices to ...
Home March 28, 2019
Home
News | Stroke

March 27, 2019 — Training interventional radiologists to perform endovascular thrombectomies results in positive ...

Home March 27, 2019
Home
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.
Feature | ACC | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...
Home March 27, 2019
Home
News | Structural Heart Occluders

March 27. 2019 — A newly released expert consensus statement provides recommendations for the safe and effective ...

Home March 27, 2019
Home
News | Heart Valve Technology

March 27, 2019 — The Centers for Medicare and Medicaid Services (CMS) proposed to update its national coverage policy ...

Home March 27, 2019
Home
Illustration showing the venous implantation route and where the inlet and outflow ports are when the Abiomed Impella RP is placed in the right side of the heart. The  Impella RP catheter is used for right heart hemodynamic support.
Feature | Hemodynamic Support Devices | Perwaiz Meraj, M.D. FACC and Uma Chandrasekaran, Ph.D.

Right heart failure (RHF) is a syndrome characterized by the inability of the right ventricle (RV) to support optimal ...

Home March 26, 2019
Home
Subscribe Now